PC Pharma PLC announced unaudited earnings results for the half year ended September 30, 2012. For the six months, the company announced revenue of LKR 317,721,174 compared to LKR 323,854,254 for the same period a year ago. Profit from operating activities was LKR 47,969,403 compared to LKR 126,630,880 for the same period a year ago.

Net profit before taxation was LKR 28,529,382 compared to LKR 114,859,064 for the same period a year ago. Net profit for the period was LKR 20,541,155 compared to LKR 82,698,526 for the same period a year ago. Earnings per share was LKR 0.20 compared to LKR 0.82 for the same period a year ago.

Net cash from operating activities was LKR 65,309,768 compared to LKR 13,378,552 for the same period a year ago. Purchases of property, plant and equipment was LKR 117,420 compared to LKR 60,000 for the same period a year ago.